JPRN-jRCT2051210045进行中（未招募）1 期
ONO-7475-03: ONO-7475 Phase I Study An open-label, uncontrolled study of ONO-7475 in combination with osimertinib in EGFR gene mutation-positive non-small cell lung cancer
Osawa Masahiro0 个研究点目标入组 75 人开始时间: 2021年7月2日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Patients with stage IIIB/IIIC/IV or recurrent NSCLC, which is unsuitable for radical irradiation
- •2. Patients with confirmed EGFR gene exon 19 deletion or EGFR gene exon 21 mutation(L858R)and who are scheduled to receive osimertinib
- •3. Patient has an ECOG performance status of 0-1
排除标准
- •1. Patients with severe complication
- •2. Patients with multiple primary cancers
研究者
相似试验
进行中（未招募）
1 期
ONO-7913-04: ONO-7913 Phase 1 StudyJPRN-jRCT2051210038Hirashima Yoshinori60
招募中
1 期
ONO-4578-02:ONO-4578 Phase 1 Studynresectable colorectal cancerJPRN-jRCT2031200215Hirashima Yoshinori36
进行中（未招募）
1 期
ONO-4059-08:ONO-4059 phase 1Systemic SclerosisJPRN-jRCT2031200315Osawa Masahiro16
进行中（未招募）
1 期
ONO-7119-01:Phase I study of ONO-7119 alone and in combination with ONO-4538 in patients with solid tumorsJPRN-jRCT2031210373Hirashima Yoshinori74
招募中
1 期
ONO-7914-01:Phase I study of ONO-7914 alone and in combination with ONO-4538 in patients with solid tumorsJPRN-jRCT2031210530Hirashima Yoshinori204